UNIVERSITY OF CALIFORNIA, SAN DIEGO
Cobinamide as a disease-modifying treatment for Marfan Syndrome: optimizaation of absorption
Cobinamide as a disease-modifying treatment for Marfan Syndrome: optimizaation of absorption is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN DIEGO, up to 393883, closing May 31, 2027.
May 31, 2027
(304d left)Overview
Project Summary Marfan Syndrome (MFS) is a genetic disorder with a prevalence of ~1 in 5,000 people. Aneurysms in the ascending aorta are the most serious manifestation of the condition and can lead to sudden death due to spontaneous rupture. The aneurysms are due in part to increased oxidative stress in the smooth…